Proactiveinvestors United Kingdom GlaxoSmithKline PLC https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom GlaxoSmithKline PLC RSS feed en Sun, 05 Apr 2020 08:11:27 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) FTSE 100 makes further gains as global rally continues https://www.proactiveinvestors.co.uk/companies/news/912211/ftse-100-makes-further-gains-as-global-rally-continues-912211.html Wed, 05 Feb 2020 17:02:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/912211/ftse-100-makes-further-gains-as-global-rally-continues-912211.html GlaxoSmithKline injects cash into drug pipeline as earnings come in short https://www.proactiveinvestors.co.uk/companies/news/912248/glaxosmithkline-injects-cash-into-drug-pipeline-as-earnings-come-in-short-912248.html Wed, 05 Feb 2020 15:01:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/912248/glaxosmithkline-injects-cash-into-drug-pipeline-as-earnings-come-in-short-912248.html Health on the agenda, although coronavirus is not something Glaxo's results are likely to address https://www.proactiveinvestors.co.uk/companies/news/912154/health-on-the-agenda-although-coronavirus-is-not-something-glaxo-s-results-are-likely-to-address-912154.html Wed, 05 Feb 2020 06:00:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/912154/health-on-the-agenda-although-coronavirus-is-not-something-glaxo-s-results-are-likely-to-address-912154.html FTSE 100 starts February by closing higher, boosted by sterling, as no-deal fears resurface https://www.proactiveinvestors.co.uk/companies/news/912033/ftse-100-starts-february-by-closing-higher-boosted-by-sterling-as-no-deal-fears-resurface-912033.html Mon, 03 Feb 2020 17:00:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/912033/ftse-100-starts-february-by-closing-higher-boosted-by-sterling-as-no-deal-fears-resurface-912033.html GSK under the microscope in week ahead; BP and Royal Mail also eyed https://www.proactiveinvestors.co.uk/companies/news/911984/gsk-under-the-microscope-in-week-ahead-bp-and-royal-mail-also-eyed-911984.html Mon, 03 Feb 2020 06:00:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/911984/gsk-under-the-microscope-in-week-ahead-bp-and-royal-mail-also-eyed-911984.html GlaxoSmithKline target price upped by UBS due to HIV drug https://www.proactiveinvestors.co.uk/companies/news/911972/glaxosmithkline--target-price-upped-by-ubs-due-to-hiv-drug-911972.html Fri, 31 Jan 2020 11:21:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/911972/glaxosmithkline--target-price-upped-by-ubs-due-to-hiv-drug-911972.html GlaxoSmithKline receives HIV treatment knock-back in the USA https://www.proactiveinvestors.co.uk/companies/news/909728/glaxosmithkline-receives-hiv-treatment-knock-back-in-the-usa-909728.html Mon, 23 Dec 2019 08:37:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/909728/glaxosmithkline-receives-hiv-treatment-knock-back-in-the-usa-909728.html UBS upgrades GSK as HIV business is set to grow rapidly https://www.proactiveinvestors.co.uk/companies/news/907551/ubs-upgrades-gsk-as-hiv-business-is-set-to-grow-rapidly-907551.html Thu, 21 Nov 2019 11:16:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/907551/ubs-upgrades-gsk-as-hiv-business-is-set-to-grow-rapidly-907551.html FTSE 100 closes higher ahead of US Fed decision; drugs titans shine https://www.proactiveinvestors.co.uk/companies/news/905897/ftse-100-closes-higher-ahead-of-us-fed-decision-drugs-titans-shine-905897.html Wed, 30 Oct 2019 17:05:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/905897/ftse-100-closes-higher-ahead-of-us-fed-decision-drugs-titans-shine-905897.html GlaxoSmithKline shares close to 17-year highs as it upgrades full-year earnings forecasts https://www.proactiveinvestors.co.uk/companies/news/905943/glaxosmithkline-shares-close-to-17-year-highs-as-it-upgrades-full-year-earnings-forecasts-905943.html Wed, 30 Oct 2019 14:03:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/905943/glaxosmithkline-shares-close-to-17-year-highs-as-it-upgrades-full-year-earnings-forecasts-905943.html GSK sells two vaccines for up to €1bn https://www.proactiveinvestors.co.uk/companies/news/905232/gsk-sells-two-vaccines-for-up-to-1bn-905232.html Mon, 21 Oct 2019 09:36:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/905232/gsk-sells-two-vaccines-for-up-to-1bn-905232.html GSK recalls heartburn drug over carcinogen risk https://www.proactiveinvestors.co.uk/companies/news/904473/gsk-recalls-heartburn-drug-over-carcinogen-risk-904473.html Wed, 09 Oct 2019 12:27:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/904473/gsk-recalls-heartburn-drug-over-carcinogen-risk-904473.html GlaxoSmithKline to file blood cancer drug with regulators later this year https://www.proactiveinvestors.co.uk/companies/news/901389/glaxosmithkline-to-file-blood-cancer-drug-with-regulators-later-this-year-901389.html Fri, 23 Aug 2019 06:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901389/glaxosmithkline-to-file-blood-cancer-drug-with-regulators-later-this-year-901389.html GlaxoSmithKline develops HIV treatment that only needs to be taken six times a year https://www.proactiveinvestors.co.uk/companies/news/901287/glaxosmithkline-develops-hiv-treatment-that-only-needs-to-be-taken-six-times-a-year-901287.html Thu, 22 Aug 2019 06:56:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901287/glaxosmithkline-develops-hiv-treatment-that-only-needs-to-be-taken-six-times-a-year-901287.html GlaxoSmithKline lifts full-year guidance as profits double in second quarter https://www.proactiveinvestors.co.uk/companies/news/224434/glaxosmithkline-lifts-full-year-guidance-as-profits-double-in-second-quarter-224434.html Wed, 24 Jul 2019 12:20:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/224434/glaxosmithkline-lifts-full-year-guidance-as-profits-double-in-second-quarter-224434.html GSK names former AstraZeneca finance boss as new chairman https://www.proactiveinvestors.co.uk/companies/news/224421/gsk-names-former-astrazeneca-finance-boss-as-new-chairman-224421.html Wed, 24 Jul 2019 09:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/224421/gsk-names-former-astrazeneca-finance-boss-as-new-chairman-224421.html GlaxoSmithKline edges higher as Zejula passes late-stage ovarian cancer study with flying colours https://www.proactiveinvestors.co.uk/companies/news/223894/glaxosmithkline-edges-higher-as-zejula-passes-late-stage-ovarian-cancer-study-with-flying-colours-223894.html Mon, 15 Jul 2019 07:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/223894/glaxosmithkline-edges-higher-as-zejula-passes-late-stage-ovarian-cancer-study-with-flying-colours-223894.html GSK’s Dovato single-pill HIV treatment sails through year-long phase III trial https://www.proactiveinvestors.co.uk/companies/news/223666/gsks-dovato-single-pill-hiv-treatment-sails-through-year-long-phase-iii-trial-223666.html Wed, 10 Jul 2019 08:25:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/223666/gsks-dovato-single-pill-hiv-treatment-sails-through-year-long-phase-iii-trial-223666.html Morgan Stanley doesn’t think there’s much money to be made by investing in GSK https://www.proactiveinvestors.co.uk/companies/news/222233/morgan-stanley-doesnt-think-theres-much-money-to-be-made-by-investing-in-gsk-222233.html Mon, 17 Jun 2019 11:40:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/222233/morgan-stanley-doesnt-think-theres-much-money-to-be-made-by-investing-in-gsk-222233.html GlaxoSmithKline gets US green light for severe asthma home treatment https://www.proactiveinvestors.co.uk/companies/news/221701/glaxosmithkline-gets-us-green-light-for-severe-asthma-home-treatment-221701.html Fri, 07 Jun 2019 06:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/221701/glaxosmithkline-gets-us-green-light-for-severe-asthma-home-treatment-221701.html GSK reports 30% jump in first-quarter profits as demand for its vaccines booms https://www.proactiveinvestors.co.uk/companies/news/219473/gsk-reports-30-jump-in-first-quarter-profits-as-demand-for-its-vaccines-booms-219473.html Wed, 01 May 2019 11:48:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/219473/gsk-reports-30-jump-in-first-quarter-profits-as-demand-for-its-vaccines-booms-219473.html GlaxoSmithKline unit ViiV moves a decisive step closer to producing monthly HIV jab https://www.proactiveinvestors.co.uk/companies/news/216067/glaxosmithkline-unit-viiv-moves-a-decisive-step-closer-to-producing-monthly-hiv-jab-216067.html Fri, 08 Mar 2019 07:31:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/216067/glaxosmithkline-unit-viiv-moves-a-decisive-step-closer-to-producing-monthly-hiv-jab-216067.html UBS strips GSK of ‘buy’ recommendation on near-term fears for its ViiV HIV division https://www.proactiveinvestors.co.uk/companies/news/215126/ubs-strips-gsk-of-buy-recommendation-on-near-term-fears-for-its-viiv-hiv-division-215126.html Fri, 22 Feb 2019 10:27:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/215126/ubs-strips-gsk-of-buy-recommendation-on-near-term-fears-for-its-viiv-hiv-division-215126.html GSK to take £790mln hit from launch of Advair copycat https://www.proactiveinvestors.co.uk/companies/news/214086/gsk-to-take-790mln-hit-from-launch-of-advair-copycat-214086.html Wed, 06 Feb 2019 12:56:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/214086/gsk-to-take-790mln-hit-from-launch-of-advair-copycat-214086.html GSK chairman steps down after consumer healthcare merger with Pfizer https://www.proactiveinvestors.co.uk/companies/news/212931/gsk-chairman-steps-down-after-consumer-healthcare-merger-with-pfizer-212931.html Mon, 21 Jan 2019 15:25:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/212931/gsk-chairman-steps-down-after-consumer-healthcare-merger-with-pfizer-212931.html GlaxoSmithKline spikes higher as it inks US$12.7bn consumer healthcare deal with Pfizer https://www.proactiveinvestors.co.uk/companies/news/211466/glaxosmithkline-spikes-higher-as-it-inks-us127bn-consumer-healthcare-deal-with-pfizer-211466.html Wed, 19 Dec 2018 10:20:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/211466/glaxosmithkline-spikes-higher-as-it-inks-us127bn-consumer-healthcare-deal-with-pfizer-211466.html GlaxoSmithKline shares drift lower as Morgan Stanley reinitiates coverage with ‘underweight’ stance https://www.proactiveinvestors.co.uk/companies/news/211229/glaxosmithkline-shares-drift-lower-as-morgan-stanley-reinitiates-coverage-with-underweight-stance-211229.html Fri, 14 Dec 2018 11:20:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/211229/glaxosmithkline-shares-drift-lower-as-morgan-stanley-reinitiates-coverage-with-underweight-stance-211229.html Barclays downgrades GSK; warns of “significant EPS dilution” from Tesaro acquisition https://www.proactiveinvestors.co.uk/companies/news/210583/barclays-downgrades-gsk-warns-of-significant-eps-dilution-from-tesaro-acquisition-210583.html Wed, 05 Dec 2018 12:35:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/210583/barclays-downgrades-gsk-warns-of-significant-eps-dilution-from-tesaro-acquisition-210583.html GSK to buy US cancer drug firm Tesaro after making a Horlicks with Unilever https://www.proactiveinvestors.co.uk/companies/news/210395/gsk-to-buy-us-cancer-drug-firm-tesaro-after-making-a-horlicks-with-unilever-210395.html Mon, 03 Dec 2018 13:00:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/210395/gsk-to-buy-us-cancer-drug-firm-tesaro-after-making-a-horlicks-with-unilever-210395.html GlaxoSmithKline sells Indian Horlicks business to Unilever https://www.proactiveinvestors.co.uk/companies/news/210385/glaxosmithkline-sells-indian-horlicks-business-to-unilever-210385.html Mon, 03 Dec 2018 10:32:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/210385/glaxosmithkline-sells-indian-horlicks-business-to-unilever-210385.html GSK confirms it is considering merger of consumer healthcare unit https://www.proactiveinvestors.co.uk/companies/news/210222/gsk-confirms-it-is-considering-merger-of-consumer-healthcare-unit-210222.html Thu, 29 Nov 2018 12:33:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/210222/gsk-confirms-it-is-considering-merger-of-consumer-healthcare-unit-210222.html GSK ups full-year earnings forecasts on strong sales of Shringrix vaccine https://www.proactiveinvestors.co.uk/companies/news/208239/gsk-ups-full-year-earnings-forecasts-on-strong-sales-of-shringrix-vaccine-208239.html Wed, 31 Oct 2018 13:40:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/208239/gsk-ups-full-year-earnings-forecasts-on-strong-sales-of-shringrix-vaccine-208239.html GlaxoSmithKline releases upbeat injectable HIV treatment results https://www.proactiveinvestors.co.uk/companies/news/208158/GlaxoSmithKline-releases-upbeat-injectable-HIV-treatment-results--208158.html Tue, 30 Oct 2018 15:54:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/208158/GlaxoSmithKline-releases-upbeat-injectable-HIV-treatment-results--208158.html GSK downgraded by Liberum to 'hold' as broker sees better value elsewhere https://www.proactiveinvestors.co.uk/companies/news/203877/gsk-downgraded-by-liberum-to-hold-as-broker-sees-better-value-elsewhere-203877.html Thu, 30 Aug 2018 10:22:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/203877/gsk-downgraded-by-liberum-to-hold-as-broker-sees-better-value-elsewhere-203877.html GlaxoSmithKline offshoot makes HIV breakthrough https://www.proactiveinvestors.co.uk/companies/news/202930/glaxosmithkline-offshoot-makes-hiv-breakthrough-202930.html Wed, 15 Aug 2018 06:57:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/202930/glaxosmithkline-offshoot-makes-hiv-breakthrough-202930.html GlaxoSmithKline appoints HSBC bean counter on pay, perks package worth up to £3.4mln https://www.proactiveinvestors.co.uk/companies/news/202345/glaxosmithkline-appoints-hsbc-bean-counter-on-pay-perks-package-worth-up-to-34mln-202345.html Tue, 07 Aug 2018 06:43:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/202345/glaxosmithkline-appoints-hsbc-bean-counter-on-pay-perks-package-worth-up-to-34mln-202345.html FDA committee doesn’t think GSK’s asthma drug can be used to treat COPD as well https://www.proactiveinvestors.co.uk/companies/news/201642/fda-committee-doesnt-think-gsks-asthma-drug-can-be-used-to-treat-copd-as-well-201642.html Thu, 26 Jul 2018 10:27:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/201642/fda-committee-doesnt-think-gsks-asthma-drug-can-be-used-to-treat-copd-as-well-201642.html GSK unveils new £1.7bn cost-cutting programme as it switches tack on R&D https://www.proactiveinvestors.co.uk/companies/news/201554/gsk-unveils-new-17bn-cost-cutting-programme-as-it-switches-tack-on-rd-201554.html Wed, 25 Jul 2018 11:38:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/201554/gsk-unveils-new-17bn-cost-cutting-programme-as-it-switches-tack-on-rd-201554.html GSK publishes more positive data from HIV trials ahead of Wednesday’s Q2 update https://www.proactiveinvestors.co.uk/companies/news/201466/gsk-publishes-more-positive-data-from-hiv-trials-ahead-of-wednesdays-q2-update-201466.html Tue, 24 Jul 2018 14:17:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/201466/gsk-publishes-more-positive-data-from-hiv-trials-ahead-of-wednesdays-q2-update-201466.html GlaxoSmithKline considering business break-up following investor pressure - FT report https://www.proactiveinvestors.co.uk/companies/news/201270/glaxosmithkline-considering-business-break-up-following-investor-pressure-ft-report-201270.html Mon, 23 Jul 2018 08:15:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/201270/glaxosmithkline-considering-business-break-up-following-investor-pressure-ft-report-201270.html GlaxoSmithKline gets double target price lift from Barclays and Deutsche Bank on growth expectations https://www.proactiveinvestors.co.uk/companies/news/200044/glaxosmithkline-gets-double-target-price-lift-from-barclays-and-deutsche-bank-on-growth-expectations-200044.html Tue, 03 Jul 2018 11:44:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/200044/glaxosmithkline-gets-double-target-price-lift-from-barclays-and-deutsche-bank-on-growth-expectations-200044.html Bidding war brewing for GSK’s Indian Horlicks division, with Coca-Cola, Nestle and Kraft all reportedly interested https://www.proactiveinvestors.co.uk/companies/news/199035/bidding-war-brewing-for-gsks-indian-horlicks-division-with-coca-cola-nestle-and-kraft-all-reportedly-interested-199035.html Mon, 18 Jun 2018 10:33:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/199035/bidding-war-brewing-for-gsks-indian-horlicks-division-with-coca-cola-nestle-and-kraft-all-reportedly-interested-199035.html GlaxoSmithKline reports positive results from phase III trial of its two-drug HIV treatment https://www.proactiveinvestors.co.uk/companies/news/198853/glaxosmithkline-reports-positive-results-from-phase-iii-trial-of-its-two-drug-hiv-treatment-198853.html Thu, 14 Jun 2018 07:41:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/198853/glaxosmithkline-reports-positive-results-from-phase-iii-trial-of-its-two-drug-hiv-treatment-198853.html Glaxo makes new drug application in Japan for COPD treatment, Trelegy Ellipta https://www.proactiveinvestors.co.uk/companies/news/197805/glaxo-makes-new-drug-application-in-japan-for-copd-treatment-trelegy-ellipta-197805.html Tue, 29 May 2018 07:32:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/197805/glaxo-makes-new-drug-application-in-japan-for-copd-treatment-trelegy-ellipta-197805.html GlaxoSmithKline CFO Simon Dingemans to retire next May https://www.proactiveinvestors.co.uk/companies/news/196644/glaxosmithkline-cfo-simon-dingemans-to-retire-next-may-196644.html Wed, 09 May 2018 11:34:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/196644/glaxosmithkline-cfo-simon-dingemans-to-retire-next-may-196644.html GSK rules out Shire bid as it reports drop in quarterly earnings https://www.proactiveinvestors.co.uk/companies/news/195773/gsk-rules-out-shire-bid-as-it-reports-drop-in-quarterly-earnings-195773.html Wed, 25 Apr 2018 14:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/195773/gsk-rules-out-shire-bid-as-it-reports-drop-in-quarterly-earnings-195773.html GSK buys out consumer healthcare venture partner Novartis for US$13bn https://www.proactiveinvestors.co.uk/companies/news/193846/gsk-buys-out-consumer-healthcare-venture-partner-novartis-for-us13bn-193846.html Tue, 27 Mar 2018 12:10:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/193846/gsk-buys-out-consumer-healthcare-venture-partner-novartis-for-us13bn-193846.html GlaxoSmithKline follows Reckitt Benckiser in bowing out of US$20bn auction for Pfizer consumer division https://www.proactiveinvestors.co.uk/companies/news/193683/glaxosmithkline-follows-reckitt-benckiser-in-bowing-out-of-us20bn-auction-for-pfizer-consumer-division-193683.html Fri, 23 Mar 2018 12:09:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/193683/glaxosmithkline-follows-reckitt-benckiser-in-bowing-out-of-us20bn-auction-for-pfizer-consumer-division-193683.html GlaxoSmithKline winning over City number crunchers https://www.proactiveinvestors.co.uk/companies/news/191443/glaxosmithkline-winning-over-city-number-crunchers-191443.html Fri, 09 Feb 2018 13:37:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/191443/glaxosmithkline-winning-over-city-number-crunchers-191443.html GSK sues US rival Gilead Sciences for alleged HIV drug patent infringement https://www.proactiveinvestors.co.uk/companies/news/191364/gsk-sues-us-rival-gilead-sciences-for-alleged-hiv-drug-patent-infringement-191364.html Thu, 08 Feb 2018 08:25:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/191364/gsk-sues-us-rival-gilead-sciences-for-alleged-hiv-drug-patent-infringement-191364.html GSK warns 2018 earnings hinge on generic competition to its blockbuster Advair inhaler https://www.proactiveinvestors.co.uk/companies/news/191306/gsk-warns-2018-earnings-hinge-on-generic-competition-to-its-blockbuster-advair-inhaler-191306.html Wed, 07 Feb 2018 13:14:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/191306/gsk-warns-2018-earnings-hinge-on-generic-competition-to-its-blockbuster-advair-inhaler-191306.html Barclays cites progress in HIV and new shingles vaccine as it turns bullish on GSK https://www.proactiveinvestors.co.uk/companies/news/190167/barclays-cites-progress-in-hiv-and-new-shingles-vaccine-as-it-turns-bullish-on-gsk-190167.html Wed, 17 Jan 2018 11:00:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/190167/barclays-cites-progress-in-hiv-and-new-shingles-vaccine-as-it-turns-bullish-on-gsk-190167.html GSK edges higher as it releases “promising” new data from phase I/II blood cancer trial https://www.proactiveinvestors.co.uk/companies/news/188647/gsk-edges-higher-as-it-releases-promising-new-data-from-phase-iii-blood-cancer-trial-188647.html Tue, 12 Dec 2017 09:29:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/188647/gsk-edges-higher-as-it-releases-promising-new-data-from-phase-iii-blood-cancer-trial-188647.html GSK’s latest phase III shingles trial offers hope to stem cell transplant patients https://www.proactiveinvestors.co.uk/companies/news/188341/gsks-latest-phase-iii-shingles-trial-offers-hope-to-stem-cell-transplant-patients-188341.html Wed, 06 Dec 2017 08:43:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/188341/gsks-latest-phase-iii-shingles-trial-offers-hope-to-stem-cell-transplant-patients-188341.html GSK’s ViiV Healthcare kicks off enrolment of big phase III HIV trial in Africa https://www.proactiveinvestors.co.uk/companies/news/188041/gsks-viiv-healthcare-kicks-off-enrolment-of-big-phase-iii-hiv-trial-in-africa-188041.html Thu, 30 Nov 2017 09:41:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/188041/gsks-viiv-healthcare-kicks-off-enrolment-of-big-phase-iii-hiv-trial-in-africa-188041.html Glaxo SmithKline study triggers robust share price increase and hope for HIV sufferers https://www.proactiveinvestors.co.uk/companies/news/187852/glaxo-smithkline-study-triggers-robust-share-price-increase-and-hope-for-hiv-sufferers-187852.html Mon, 27 Nov 2017 14:44:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/187852/glaxo-smithkline-study-triggers-robust-share-price-increase-and-hope-for-hiv-sufferers-187852.html UBS reckons GSK is a ‘buy’, citing weak share price and secure dividend https://www.proactiveinvestors.co.uk/companies/news/187823/ubs-reckons-gsk-is-a-buy-citing-weak-share-price-and-secure-dividend-187823.html Mon, 27 Nov 2017 10:27:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/187823/ubs-reckons-gsk-is-a-buy-citing-weak-share-price-and-secure-dividend-187823.html GSK steals a march on rivals as its two drug, one pill HIV treatment gets green light from FDA https://www.proactiveinvestors.co.uk/companies/news/187637/gsk-steals-a-march-on-rivals-as-its-two-drug-one-pill-hiv-treatment-gets-green-light-from-fda-187637.html Wed, 22 Nov 2017 09:34:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/187637/gsk-steals-a-march-on-rivals-as-its-two-drug-one-pill-hiv-treatment-gets-green-light-from-fda-187637.html New HIV and lung drugs help boost GSK’s Q3 sales but investors hoped for more https://www.proactiveinvestors.co.uk/companies/news/186191/new-hiv-and-lung-drugs-help-boost-gsks-q3-sales-but-investors-hoped-for-more-186191.html Wed, 25 Oct 2017 14:16:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/186191/new-hiv-and-lung-drugs-help-boost-gsks-q3-sales-but-investors-hoped-for-more-186191.html GSK gets approvals for 'bubble boy' syndrome gene therapy in UK and shingles vaccine in US https://www.proactiveinvestors.co.uk/companies/news/186011/gsk-gets-approvals-for-bubble-boy-syndrome-gene-therapy-in-uk-and-shingles-vaccine-in-us-186011.html Mon, 23 Oct 2017 07:34:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/186011/gsk-gets-approvals-for-bubble-boy-syndrome-gene-therapy-in-uk-and-shingles-vaccine-in-us-186011.html GlaxoSmithKline gets 'positive opinion' from EMA panel for three-in-one inhaled COPD treatment https://www.proactiveinvestors.co.uk/companies/news/184053/glaxosmithkline-gets-positive-opinion-from-ema-panel-for-three-in-one-inhaled-copd-treatment-184053.html Fri, 15 Sep 2017 08:14:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/184053/glaxosmithkline-gets-positive-opinion-from-ema-panel-for-three-in-one-inhaled-copd-treatment-184053.html GSK asthma study results published in medical journal and presented at industry meeting https://www.proactiveinvestors.co.uk/companies/news/183738/gsk-asthma-study-results-published-in-medical-journal-and-presented-at-industry-meeting-183738.html Mon, 11 Sep 2017 14:02:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/183738/gsk-asthma-study-results-published-in-medical-journal-and-presented-at-industry-meeting-183738.html GlaxoSmithKline boss Walmsley unveils restructuring plan; earnings downgrade hits shares https://www.proactiveinvestors.co.uk/companies/news/181488/glaxosmithkline-boss-walmsley-unveils-restructuring-plan-earnings-downgrade-hits-shares-181488.html Wed, 26 Jul 2017 14:41:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/181488/glaxosmithkline-boss-walmsley-unveils-restructuring-plan-earnings-downgrade-hits-shares-181488.html GlaxoSmithKline shares ease as new boss Walmsley looks to streamline pharma business https://www.proactiveinvestors.co.uk/companies/news/181494/glaxosmithkline-shares-ease-as-new-boss-walmsley-looks-to-streamline-pharma-business-181494.html Wed, 26 Jul 2017 13:41:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/181494/glaxosmithkline-shares-ease-as-new-boss-walmsley-looks-to-streamline-pharma-business-181494.html Much to ponder for GlaxoSmithKline's new boss https://www.proactiveinvestors.co.uk/companies/news/278226/much-to-ponder-for-glaxosmithkline-s-new-boss-28226.html Thu, 20 Jul 2017 13:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/278226/much-to-ponder-for-glaxosmithkline-s-new-boss-28226.html GSK confirms plans to sell Horlicks in the UK and cut 320 jobs as it prioritises drugs business https://www.proactiveinvestors.co.uk/companies/news/181142/gsk-confirms-plans-to-sell-horlicks-in-the-uk-and-cut-320-jobs-as-it-prioritises-drugs-business-181142.html Wed, 19 Jul 2017 14:10:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/181142/gsk-confirms-plans-to-sell-horlicks-in-the-uk-and-cut-320-jobs-as-it-prioritises-drugs-business-181142.html GlaxoSmithkline - Broker downgrade wipes £1.4bn from the value of Europe's largest drug maker https://www.proactiveinvestors.co.uk/companies/news/180372/glaxosmithkline-broker-downgrade-wipes-14bn-from-the-value-of-europe-s-largest-drug-maker-180372.html Wed, 05 Jul 2017 08:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/180372/glaxosmithkline-broker-downgrade-wipes-14bn-from-the-value-of-europe-s-largest-drug-maker-180372.html Liberum Capital downgrades European pharma sector to 'neutral', but remains positive on GlaxoSmithKline and AstraZeneca https://www.proactiveinvestors.co.uk/companies/news/179223/liberum-capital-downgrades-european-pharma-sector-to-neutral-but-remains-positive-on-glaxosmithkline-and-astrazeneca-179223.html Wed, 14 Jun 2017 09:03:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/179223/liberum-capital-downgrades-european-pharma-sector-to-neutral-but-remains-positive-on-glaxosmithkline-and-astrazeneca-179223.html GlaxoSmithKline makes submissions for key HIV single-tablet treatment to both the EMA and the US FDA https://www.proactiveinvestors.co.uk/companies/news/178687/glaxosmithkline-makes-submissions-for-key-hiv-single-tablet-treatment-to-both-the-ema-and-the-us-fda-178687.html Fri, 02 Jun 2017 08:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/178687/glaxosmithkline-makes-submissions-for-key-hiv-single-tablet-treatment-to-both-the-ema-and-the-us-fda-178687.html GlaxoSmithkline: Long-term value emerging, says broker https://www.proactiveinvestors.co.uk/companies/news/178381/glaxosmithkline-long-term-value-emerging-says-broker-178381.html Fri, 26 May 2017 08:49:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/178381/glaxosmithkline-long-term-value-emerging-says-broker-178381.html GlaxoSmithKline shares weak despite being on track to deliver its financial targets for 2017 under new boss Emma Walmsley https://www.proactiveinvestors.co.uk/companies/news/176929/glaxosmithkline-shares-weak-despite-being-on-track-to-deliver-its-financial-targets-for-2017-under-new-boss-emma-walmsley-176929.html Wed, 26 Apr 2017 13:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/176929/glaxosmithkline-shares-weak-despite-being-on-track-to-deliver-its-financial-targets-for-2017-under-new-boss-emma-walmsley-176929.html GSK on its way to £18, says Mir https://www.proactiveinvestors.co.uk/companies/news/306963/gsk-on-its-way-to-18-says-mir-6963.html Wed, 22 Feb 2017 10:15:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/306963/gsk-on-its-way-to-18-says-mir-6963.html Drugs-crazed shoot-out: which investment is best out of Astra, Glaxo and Shire? https://www.proactiveinvestors.co.uk/companies/news/173321/drugs-crazed-shoot-out-which-investment-is-best-out-of-astra-glaxo-and-shire-173321.html Sat, 18 Feb 2017 09:53:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/173321/drugs-crazed-shoot-out-which-investment-is-best-out-of-astra-glaxo-and-shire-173321.html GSK announces positive study results for HIV treatment https://www.proactiveinvestors.co.uk/companies/news/173108/gsk-announces-positive-study-results-for-hiv-treatment-173108.html Tue, 14 Feb 2017 12:14:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/173108/gsk-announces-positive-study-results-for-hiv-treatment-173108.html GSK a ‘decent risk-reward trade’; shares could top £17 https://www.proactiveinvestors.co.uk/companies/news/306889/gsk-a-decent-risk-reward-trade-shares-could-top-17-6889.html Thu, 09 Feb 2017 09:30:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/306889/gsk-a-decent-risk-reward-trade-shares-could-top-17-6889.html Glaxo braces itself for £1bn Advair hit https://www.proactiveinvestors.co.uk/companies/news/172860/glaxo-braces-itself-for-1bn-advair-hit-172860.html Wed, 08 Feb 2017 16:30:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/172860/glaxo-braces-itself-for-1bn-advair-hit-172860.html GlaxoSmithKline could receive further Brexit boost, says broker https://www.proactiveinvestors.co.uk/companies/news/171673/glaxosmithkline-could-receive-further-brexit-boost-says-broker-171673.html Mon, 16 Jan 2017 12:35:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/171673/glaxosmithkline-could-receive-further-brexit-boost-says-broker-171673.html GSK ‘looks like a technical buy’ for 2017 https://www.proactiveinvestors.co.uk/companies/news/306660/gsk-looks-like-a-technical-buy-for-2017-6660.html Mon, 02 Jan 2017 07:30:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/306660/gsk-looks-like-a-technical-buy-for-2017-6660.html GlaxoSmithKline’s fast-growing HIV drug business gets another boost https://www.proactiveinvestors.co.uk/companies/news/170732/glaxosmithklines-fast-growing-hiv-drug-business-gets-another-boost-170732.html Tue, 20 Dec 2016 10:04:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/170732/glaxosmithklines-fast-growing-hiv-drug-business-gets-another-boost-170732.html GlaxoSmithKline's shingles vaccine filed in Europe https://www.proactiveinvestors.co.uk/companies/news/169540/glaxosmithkline-s-shingles-vaccine-filed-in-europe-169540.html Fri, 25 Nov 2016 14:52:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/169540/glaxosmithkline-s-shingles-vaccine-filed-in-europe-169540.html Brokers: UK pharma giants in good shape if Clinton wins says Citigroup https://www.proactiveinvestors.co.uk/companies/news/276458/brokers-uk-pharma-giants-in-good-shape-if-clinton-wins-says-citigroup-26458.html Mon, 07 Nov 2016 14:22:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/276458/brokers-uk-pharma-giants-in-good-shape-if-clinton-wins-says-citigroup-26458.html GlaxoSmithKline shares are outperforming AstraZeneca https://www.proactiveinvestors.co.uk/companies/news/306269/glaxosmithkline-shares-are-outperforming-astrazeneca-6269.html Thu, 27 Oct 2016 12:13:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/306269/glaxosmithkline-shares-are-outperforming-astrazeneca-6269.html GlaxoSmithKline medicine goes down well in City https://www.proactiveinvestors.co.uk/companies/news/168148/glaxosmithkline-medicine-goes-down-well-in-city-168148.html Thu, 27 Oct 2016 11:37:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/168148/glaxosmithkline-medicine-goes-down-well-in-city-168148.html US FDA approval for shingles vaccine eyed by Glaxo https://www.proactiveinvestors.co.uk/companies/news/167841/us-fda-approval-for-shingles-vaccine-eyed-by-glaxo-167841.html Mon, 24 Oct 2016 12:54:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/167841/us-fda-approval-for-shingles-vaccine-eyed-by-glaxo-167841.html GSK seeks US green light for shingles vaccine https://www.proactiveinvestors.co.uk/companies/news/167814/gsk-seeks-us-green-light-for-shingles-vaccine-167814.html Mon, 24 Oct 2016 06:44:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/167814/gsk-seeks-us-green-light-for-shingles-vaccine-167814.html A solid, defensive play for yield investors, but just what could sink GSK? https://www.proactiveinvestors.co.uk/companies/news/167641/a-solid-defensive-play-for-yield-investors-but-just-what-could-sink-gsk-167641.html Thu, 20 Oct 2016 05:32:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/167641/a-solid-defensive-play-for-yield-investors-but-just-what-could-sink-gsk-167641.html GSK has been a Brexit winner, but can the FTSE share go higher? https://www.proactiveinvestors.co.uk/companies/news/167014/gsk-has-been-a-brexit-winner-but-can-the-ftse-share-go-higher-167014.html Sat, 08 Oct 2016 07:39:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/167014/gsk-has-been-a-brexit-winner-but-can-the-ftse-share-go-higher-167014.html GSK shares tipped to strength further, to help FTSE 100 consolidate above 7,000 https://www.proactiveinvestors.co.uk/companies/news/306130/gsk-shares-tipped-to-strength-further-to-help-ftse-100-consolidate-above-7000-6130.html Thu, 06 Oct 2016 06:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/306130/gsk-shares-tipped-to-strength-further-to-help-ftse-100-consolidate-above-7000-6130.html GlaxoSmithKline's choice of new boss disappoints City https://www.proactiveinvestors.co.uk/companies/news/166150/glaxosmithkline-s-choice-of-new-boss-disappoints-city-166150.html Tue, 20 Sep 2016 11:35:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/166150/glaxosmithkline-s-choice-of-new-boss-disappoints-city-166150.html GlaxoSmithKline's shingles vaccine lasts four years in elderly patients https://www.proactiveinvestors.co.uk/companies/news/165930/glaxosmithkline-s-shingles-vaccine-lasts-four-years-in-elderly-patients-165930.html Thu, 15 Sep 2016 09:20:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/165930/glaxosmithkline-s-shingles-vaccine-lasts-four-years-in-elderly-patients-165930.html GlaxosmithKline hails double drug successes https://www.proactiveinvestors.co.uk/companies/news/147675/glaxosmithkline-hails-double-drug-successes-147675.html Mon, 05 Sep 2016 14:15:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/147675/glaxosmithkline-hails-double-drug-successes-147675.html GlaxosmithKline teams up with Google sister firm in bioelectronics venture https://www.proactiveinvestors.co.uk/companies/news/128836/glaxosmithkline-teams-up-with-google-sister-firm-in-bioelectronics-venture-128836.html Mon, 01 Aug 2016 07:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/128836/glaxosmithkline-teams-up-with-google-sister-firm-in-bioelectronics-venture-128836.html GlaxoSmithKline upbeat despite currency hit https://www.proactiveinvestors.co.uk/companies/news/128698/glaxosmithkline-upbeat-despite-currency-hit-128698.html Wed, 27 Jul 2016 12:26:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/128698/glaxosmithkline-upbeat-despite-currency-hit-128698.html GlaxoSmithKline given a shot in the arm by Jefferies https://www.proactiveinvestors.co.uk/companies/news/275474/glaxosmithkline-given-a-shot-in-the-arm-by-jefferies-25474.html Thu, 14 Jul 2016 09:27:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/275474/glaxosmithkline-given-a-shot-in-the-arm-by-jefferies-25474.html Glaxo/Innoviva triple combo COPD treatment passes phase III https://www.proactiveinvestors.co.uk/companies/news/127287/glaxoinnoviva-triple-combo-copd-treatment-passes-phase-iii-127287.html Mon, 20 Jun 2016 07:46:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/127287/glaxoinnoviva-triple-combo-copd-treatment-passes-phase-iii-127287.html GlaxoSmithKline hails progress with lung disease treatment https://www.proactiveinvestors.co.uk/companies/news/126330/glaxosmithkline-hails-progress-with-lung-disease-treatment-126330.html Tue, 24 May 2016 14:24:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/126330/glaxosmithkline-hails-progress-with-lung-disease-treatment-126330.html Glaxosmithkline meningitis vaccine achieves endpoints https://www.proactiveinvestors.co.uk/companies/news/125926/glaxosmithkline-meningitis-vaccine-achieves-endpoints-125926.html Fri, 13 May 2016 13:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/125926/glaxosmithkline-meningitis-vaccine-achieves-endpoints-125926.html GlaxoSmithKline recovery on track claims chief https://www.proactiveinvestors.co.uk/companies/news/125311/glaxosmithkline-recovery-on-track-claims-chief-125311.html Wed, 27 Apr 2016 13:33:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/125311/glaxosmithkline-recovery-on-track-claims-chief-125311.html GlaxoSmithKline PLC boss to quit in 2017 amid shake-up talk https://www.proactiveinvestors.co.uk/companies/news/123788/glaxosmithkline-plc-boss-to-quit-in-2017-amid-shake-up-talk-123788.html Thu, 17 Mar 2016 13:50:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/123788/glaxosmithkline-plc-boss-to-quit-in-2017-amid-shake-up-talk-123788.html GlaxoSmithKline launches hunt for new chief executive https://www.proactiveinvestors.co.uk/companies/news/123072/glaxosmithkline-launches-hunt-for-new-chief-executive-123072.html Mon, 29 Feb 2016 08:40:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/123072/glaxosmithkline-launches-hunt-for-new-chief-executive-123072.html Glaxo fined £38mln for Seroxat deal 15 years ago https://www.proactiveinvestors.co.uk/companies/news/122471/glaxo-fined-38mln-for-seroxat-deal-15-years-ago-122471.html Fri, 12 Feb 2016 13:58:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/122471/glaxo-fined-38mln-for-seroxat-deal-15-years-ago-122471.html GlaxoSmithKline gets shot in arm but M&A talk trundles on https://www.proactiveinvestors.co.uk/companies/news/122130/glaxosmithkline-gets-shot-in-arm-but-ma-talk-trundles-on-122130.html Wed, 03 Feb 2016 16:20:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/122130/glaxosmithkline-gets-shot-in-arm-but-ma-talk-trundles-on-122130.html GlaxoSmithKline earnings fall but on track to save £3bn https://www.proactiveinvestors.co.uk/companies/news/122110/glaxosmithkline-earnings-fall-but-on-track-to-save-3bn-122110.html Wed, 03 Feb 2016 12:35:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/122110/glaxosmithkline-earnings-fall-but-on-track-to-save-3bn-122110.html Buyer beware: Be picky with those high-yield Footsie stocks https://www.proactiveinvestors.co.uk/companies/news/120789/buyer-beware-be-picky-with-those-high-yield-footsie-stocks-120789.html Thu, 24 Dec 2015 07:51:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/120789/buyer-beware-be-picky-with-those-high-yield-footsie-stocks-120789.html GlaxoSmithKline pins future on 40 new drugs https://www.proactiveinvestors.co.uk/companies/news/117018/glaxosmithkline-pins-future-on-40-new-drugs-117018.html Tue, 03 Nov 2015 13:04:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/117018/glaxosmithkline-pins-future-on-40-new-drugs-117018.html Deutsche upbeat on Glaxo; lifts price target https://www.proactiveinvestors.co.uk/companies/news/273495/deutsche-upbeat-on-glaxo-lifts-price-target-23495.html Fri, 30 Oct 2015 15:01:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/273495/deutsche-upbeat-on-glaxo-lifts-price-target-23495.html GlaxoSmithKline tops expectations https://www.proactiveinvestors.co.uk/companies/news/116777/glaxosmithkline-tops-expectations-116777.html Wed, 28 Oct 2015 14:45:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/116777/glaxosmithkline-tops-expectations-116777.html Glaxo's study results more bad than good reckons JP Morgan https://www.proactiveinvestors.co.uk/companies/news/273475/glaxo-s-study-results-more-bad-than-good-reckons-jp-morgan-23475.html Wed, 28 Oct 2015 11:11:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/273475/glaxo-s-study-results-more-bad-than-good-reckons-jp-morgan-23475.html Glaxosmithkline reports positive results from HIV drug tests https://www.proactiveinvestors.co.uk/companies/news/111056/glaxosmithkline-reports-positive-results-from-hiv-drug-tests-111056.html Wed, 23 Sep 2015 10:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/111056/glaxosmithkline-reports-positive-results-from-hiv-drug-tests-111056.html GlaxoSmithKline sells MS drug rights to Novartis for US$1bn https://www.proactiveinvestors.co.uk/companies/news/110157/glaxosmithkline-sells-ms-drug-rights-to-novartis-for-us1bn-110157.html Fri, 21 Aug 2015 06:20:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/110157/glaxosmithkline-sells-ms-drug-rights-to-novartis-for-us1bn-110157.html FTSE 100 buoyed by miners and more pharma bid gossip https://www.proactiveinvestors.co.uk/companies/news/109670/ftse-100-buoyed-by-miners-and-more-pharma-bid-gossip-109670.html Wed, 05 Aug 2015 16:05:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/109670/ftse-100-buoyed-by-miners-and-more-pharma-bid-gossip-109670.html Glaxo to re-emerge from negative cycle, BarCap says https://www.proactiveinvestors.co.uk/companies/news/109600/Glaxo-to-re-emerge-from-negative-cycle-BarCap-says-109600.html Mon, 03 Aug 2015 08:54:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/109600/Glaxo-to-re-emerge-from-negative-cycle-BarCap-says-109600.html GlaxoSmithKline hails new drugs as sales rise https://www.proactiveinvestors.co.uk/companies/news/109466/glaxosmithkline-hails-new-drugs-as-sales-rise-109466.html Wed, 29 Jul 2015 11:54:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/109466/glaxosmithkline-hails-new-drugs-as-sales-rise-109466.html Glaxo shares rise as Witty sets out long-term plan https://www.proactiveinvestors.co.uk/companies/news/68737/glaxo-shares-rise-as-witty-sets-out-long-term-plan-80050.html Wed, 06 May 2015 12:36:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/68737/glaxo-shares-rise-as-witty-sets-out-long-term-plan-80050.html Recuperating pipeline to boost Glaxo https://www.proactiveinvestors.co.uk/companies/news/266662/-16662.html Glaxo appears set to benefit from improved prospects this year and recent renewed speculation that Pfizer might be interested in a bid.

]]>
Sat, 02 May 2015 07:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/266662/-16662.html
GlaxoSmithKline asset swap done; now for the £4bn handback https://www.proactiveinvestors.co.uk/companies/news/66680/glaxosmithkline-asset-swap-done-now-for-the-4bn-handback--77806.html Mon, 02 Mar 2015 07:49:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/66680/glaxosmithkline-asset-swap-done-now-for-the-4bn-handback--77806.html Glaxo shares lifted as expects stronger performance in second half https://www.proactiveinvestors.co.uk/companies/news/65912/glaxo-shares-lifted-as-expects-stronger-performance-in-second-half--76950.html Wed, 04 Feb 2015 12:19:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/65912/glaxo-shares-lifted-as-expects-stronger-performance-in-second-half--76950.html GlaxoSmithKline downgraded, AstraZeneca upgraded as JP MorganCazenove says sector is fully valued https://www.proactiveinvestors.co.uk/companies/news/64986/glaxosmithkline-downgraded-astrazeneca-upgraded-as-jp-morgancazenove-says-sector-is-fully-valued-75893.html The pharmaceutical sector is approaching fair value after a stellar run in 2014, according to the broking heavyweight JP Morgan Cazenove.

]]>
Mon, 05 Jan 2015 10:28:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/64986/glaxosmithkline-downgraded-astrazeneca-upgraded-as-jp-morgancazenove-says-sector-is-fully-valued-75893.html
GlaxoSmithKline lifted by plans to hive off HIV treatment business https://www.proactiveinvestors.co.uk/companies/news/62934/glaxosmithkline-lifted-by-plans-to-hive-off-hiv-treatment-business-73529.html Wed, 22 Oct 2014 14:22:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/62934/glaxosmithkline-lifted-by-plans-to-hive-off-hiv-treatment-business-73529.html Glaxo fined £297mln over bribery in China https://www.proactiveinvestors.co.uk/companies/news/61919/glaxo-fined-297mln-over-bribery-in-china-72423.html Fri, 19 Sep 2014 09:25:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/61919/glaxo-fined-297mln-over-bribery-in-china-72423.html GlaxoSmithKline sales on the slide as US, Chinese woes mount https://www.proactiveinvestors.co.uk/companies/news/60231/glaxosmithkline-sales-on-the-slide-as-us-chinese-woes-mount-70628.html Shares in GlaxoSmithKline dived as the revenues and profits slumped with increased competition, currency headwinds and supply issues adding to its bribery problems in China.

]]>
Wed, 23 Jul 2014 13:24:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/60231/glaxosmithkline-sales-on-the-slide-as-us-chinese-woes-mount-70628.html
GlaxoSmithKline under investigation by the SFO https://www.proactiveinvestors.co.uk/companies/news/58604/glaxosmithkline-under-investigation-by-the-sfo-68908.html Wed, 28 May 2014 07:55:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/58604/glaxosmithkline-under-investigation-by-the-sfo-68908.html GlaxoSmithKline "deeply concerned" by China bribery charges https://www.proactiveinvestors.co.uk/companies/news/58231/glaxosmithkline-deeply-concerned-by-china-bribery-charges-68505.html Wed, 14 May 2014 09:03:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/58231/glaxosmithkline-deeply-concerned-by-china-bribery-charges-68505.html GlaxoSmithKline receives FDA approval for respiratory drug https://www.proactiveinvestors.co.uk/companies/news/57870/glaxosmithkline-receives-fda-approval-for-respiratory-drug-68126.html Thu, 01 May 2014 07:33:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/57870/glaxosmithkline-receives-fda-approval-for-respiratory-drug-68126.html UPDATE - Dormant drugmakers awoken by megadeals https://www.proactiveinvestors.co.uk/companies/news/57552/update-dormant-drugmakers-awoken-by-megadeals-67792.html Talk of major deal-making has rekindled interest in the recently inactive pharmaceutical industry, propelling shares in Britain’s biggest drug makers higher.

]]>
Tue, 22 Apr 2014 12:18:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/57552/update-dormant-drugmakers-awoken-by-megadeals-67792.html
New medicine should help Glaxo recover https://www.proactiveinvestors.co.uk/companies/news/264413/new-medicine-should-help-glaxo-recover-15978.html GlaxoSmithKline has 13 significant drugs in the final stage of testing, the results of which are expected during the coming 12 months.


]]>
Sat, 19 Apr 2014 07:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/264413/new-medicine-should-help-glaxo-recover-15978.html
GlaxoSmithKline suffers cancer drug setback https://www.proactiveinvestors.co.uk/companies/news/56667/glaxosmithkline-suffers-cancer-drug-setback-66861.html Thu, 20 Mar 2014 08:44:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/56667/glaxosmithkline-suffers-cancer-drug-setback-66861.html GlaxoSmithKline talks up its pipeline https://www.proactiveinvestors.co.uk/companies/news/55439/glaxosmithkline-talks-up-its-pipeline-65551.html Wed, 05 Feb 2014 13:45:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/55439/glaxosmithkline-talks-up-its-pipeline-65551.html Country risk key ingredient in investment mix https://www.proactiveinvestors.co.uk/companies/news/54443/country-risk-key-ingredient-in-investment-mix-64477.html Faltering growth and weakening currencies, exacerbated by the mining downturn, has forced regimes to come up with new ways to drive economic growth.

]]>
Fri, 27 Dec 2013 11:01:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/54443/country-risk-key-ingredient-in-investment-mix-64477.html
GlaxoSmithKline hit by failure of heart drug https://www.proactiveinvestors.co.uk/companies/news/53181/glaxosmithkline-hit-by-failure-of-heart-drug-63134.html Tue, 12 Nov 2013 10:11:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/53181/glaxosmithkline-hit-by-failure-of-heart-drug-63134.html JP Morgan Cazenove cuts Glaxo price target by £1.50 https://www.proactiveinvestors.co.uk/companies/news/52802/jp-morgan-cazenove-cuts-glaxo-price-target-by-150-62711.html Wed, 30 Oct 2013 09:49:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/52802/jp-morgan-cazenove-cuts-glaxo-price-target-by-150-62711.html Glaxo's China sales crash https://www.proactiveinvestors.co.uk/companies/news/52582/glaxos-china-sales-crash--62459.html Wed, 23 Oct 2013 12:28:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/52582/glaxos-china-sales-crash--62459.html Glaxo suffers Credit Suisse downgrade https://www.proactiveinvestors.co.uk/companies/news/52205/glaxo-suffers-credit-suisse-downgrade-62023.html Thu, 10 Oct 2013 12:29:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/52205/glaxo-suffers-credit-suisse-downgrade-62023.html Glaxo looks set to heal https://www.proactiveinvestors.co.uk/companies/news/262623/glaxo-looks-set-to-heal-14169.html The improved product pipeline leaves the fundamental story looking stronger than it has for some time, which combined with the enticing technicals, indicates a strong investment case. 

]]>
Sat, 21 Sep 2013 07:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/262623/glaxo-looks-set-to-heal-14169.html
Glaxo and Astra's respiratory prospects leave Jefferies far from breathless https://www.proactiveinvestors.co.uk/companies/news/51371/glaxo-and-astras-respiratory-prospects-leave-jefferies-far-from-breathless-61077.html Fri, 13 Sep 2013 12:04:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/51371/glaxo-and-astras-respiratory-prospects-leave-jefferies-far-from-breathless-61077.html GlaxoSmithKline gets US approval for smoker's cough treatment https://www.proactiveinvestors.co.uk/companies/news/51268/glaxosmithkline-gets-us-approval-for-smokers-cough-treatment-60963.html Wed, 11 Sep 2013 09:13:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/51268/glaxosmithkline-gets-us-approval-for-smokers-cough-treatment-60963.html Glaxo sells Lucozade and Ribena for £1.35bn https://www.proactiveinvestors.co.uk/companies/news/51184/glaxo-sells-lucozade-and-ribena-for-135bn-60871.html Mon, 09 Sep 2013 08:57:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/51184/glaxo-sells-lucozade-and-ribena-for-135bn-60871.html GlaxoSmithKline suffers cancer treatment trial setback https://www.proactiveinvestors.co.uk/companies/news/51104/glaxosmithkline-suffers-cancer-treatment-trial-setback-60782.html Thu, 05 Sep 2013 09:54:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/51104/glaxosmithkline-suffers-cancer-treatment-trial-setback-60782.html GlaxoSmithKline HIV drug gets FDA approval https://www.proactiveinvestors.co.uk/companies/news/50394/glaxosmithkline-hiv-drug-gets-fda-approval-59982.html Tue, 13 Aug 2013 07:36:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/50394/glaxosmithkline-hiv-drug-gets-fda-approval-59982.html GSK, a China Crisis? https://www.proactiveinvestors.co.uk/companies/news/262130/gsk-a-china-crisis-13666.html Scandal-hit pharma giant GlaxoSmithKline’s share price is in an unusual place. 

]]>
Fri, 26 Jul 2013 17:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/262130/gsk-a-china-crisis-13666.html
UPDATE: GlaxoSmithKline CEO Witty warns Chinese scandal will hurt business https://www.proactiveinvestors.co.uk/companies/news/49843/update-glaxosmithkline-ceo-witty-warns-chinese-scandal-will-hurt-business-59348.html GlaxoSmithKline’s boss Andrew Witty conceded today the Chinese corruption scandal will have an impact on the company, but could not say how big it would be

]]>
Wed, 24 Jul 2013 16:54:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/49843/update-glaxosmithkline-ceo-witty-warns-chinese-scandal-will-hurt-business-59348.html
GlaxoSmithKline bribery goes back to 2007, Chinese ministry alleges https://www.proactiveinvestors.co.uk/companies/news/49551/glaxosmithkline-bribery-goes-back-to-2007-chinese-ministry-alleges-59012.html Mon, 15 Jul 2013 12:36:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/49551/glaxosmithkline-bribery-goes-back-to-2007-chinese-ministry-alleges-59012.html GlaxoSmithKline execs admit to bribery and tax violations, say Chinese authorities https://www.proactiveinvestors.co.uk/companies/news/49455/glaxosmithkline-execs-admit-to-bribery-and-tax-violations-say-chinese-authorities-58900.html Thu, 11 Jul 2013 09:52:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/49455/glaxosmithkline-execs-admit-to-bribery-and-tax-violations-say-chinese-authorities-58900.html Immunotherapies offer hope to cancer patients and investors https://www.proactiveinvestors.co.uk/companies/news/48079/immunotherapies-offer-hope-to-cancer-patients-and-investors-57302.html Immunotherapies that use the body’s immune system to eliminate or slow the growth of the disease are transforming the world’s second largest killer into a chronic but treatable ailment.

]]>
Mon, 27 May 2013 15:02:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/48079/immunotherapies-offer-hope-to-cancer-patients-and-investors-57302.html
Uncertain prognosis at Glaxo https://www.proactiveinvestors.co.uk/companies/news/261297/uncertain-prognosis-at-glaxo-12808.html

Market leader GlaxoSmithKline (LON:GSK) has gained over 30% this year, despite this week reporting a 12% slide in core pre-tax profit to £1.8 billion.

]]>
Sat, 27 Apr 2013 07:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/261297/uncertain-prognosis-at-glaxo-12808.html
Glaxo puts Lucozade and Ribena up for sale https://www.proactiveinvestors.co.uk/companies/news/47120/glaxo-puts-lucozade-and-ribena-up-for-sale-56183.html Wed, 24 Apr 2013 15:09:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/47120/glaxo-puts-lucozade-and-ribena-up-for-sale-56183.html GlaxoSmithKline shares drop as OFT launches probe https://www.proactiveinvestors.co.uk/companies/news/46965/glaxosmithkline-shares-drop-as-oft-launches-probe--56004.html Fri, 19 Apr 2013 12:12:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/46965/glaxosmithkline-shares-drop-as-oft-launches-probe--56004.html Glaxo puts "iconic" brands under review as profits slide https://www.proactiveinvestors.co.uk/companies/news/44725/glaxo-puts-iconic-brands-under-review-as-profits-slide-53367.html Wed, 06 Feb 2013 12:24:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/44725/glaxo-puts-iconic-brands-under-review-as-profits-slide-53367.html Prescribe Glaxo for pipeline support https://www.proactiveinvestors.co.uk/companies/news/259777/prescribe-glaxo-for-pipeline-support-11254.html Despite difficult conditions in Europe, Glaxo’s lowly valuation, strong dividend and share buybacks should support the share price, while its strong product pipeline and emerging markets exposure should drive growth going forwards.

]]>
Sat, 17 Nov 2012 07:00:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/259777/prescribe-glaxo-for-pipeline-support-11254.html
Will GSK need a Flu Jab? https://www.proactiveinvestors.co.uk/companies/news/259644/will-gsk-need-a-flu-jab-11110.html A drop which is part of a shares normal price cycle tends to follow a degree of timeframe logic. To cancel this drop logic, the price would currently require CLOSURE above 1442p

]]>
Fri, 02 Nov 2012 17:00:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/259644/will-gsk-need-a-flu-jab-11110.html
Glaxo gets the thumbs up, AstraZeneca downgraded as Merrill gives its verdict on drugs stocks https://www.proactiveinvestors.co.uk/companies/news/40149/glaxo-gets-the-thumbs-up-astrazeneca-downgraded-as-merrill-gives-its-verdict-on-drugs-stocks-47904.html European drugs stocks offer growth potential, income and value, according to blue-chip broker Bank of America Merrill Lynch, which today named GlaxoSmithKline as one of its top large-cap picks. 

]]>
Mon, 10 Sep 2012 13:44:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/40149/glaxo-gets-the-thumbs-up-astrazeneca-downgraded-as-merrill-gives-its-verdict-on-drugs-stocks-47904.html
GlaxoSmithKline has not been idle this year https://www.proactiveinvestors.co.uk/companies/news/258989/glaxosmithkline-has-not-been-idle-this-year-10444.html Wed, 29 Aug 2012 15:15:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/258989/glaxosmithkline-has-not-been-idle-this-year-10444.html GlaxoSmithKline looking toppy after good run suggests UBS https://www.proactiveinvestors.co.uk/companies/news/39688/glaxosmithkline-looking-toppy-after-good-run-suggests-ubs-47381.html Tue, 28 Aug 2012 11:13:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/39688/glaxosmithkline-looking-toppy-after-good-run-suggests-ubs-47381.html JP Morgan Cazenove downgrades GlaxoSmithKline to 'underweight' https://www.proactiveinvestors.co.uk/companies/news/39512/jp-morgan-cazenove-downgrades-glaxosmithkline-to-underweight-47180.html Wed, 22 Aug 2012 09:55:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/39512/jp-morgan-cazenove-downgrades-glaxosmithkline-to-underweight-47180.html GlaxoSmithKline dropped from broker’s buy list on growth slowdown https://www.proactiveinvestors.co.uk/companies/news/39141/glaxosmithkline-dropped-from-brokers-buy-list-on-growth-slowdown-46742.html The pharmaceutical giant has been downgraded to 'hold' from 'buy' as Jefferies is less optimistic about the company’s potential for growth.

 

]]>
Mon, 13 Aug 2012 10:13:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/39141/glaxosmithkline-dropped-from-brokers-buy-list-on-growth-slowdown-46742.html
GlaxoSmithKline sales hurt by European price cuts https://www.proactiveinvestors.co.uk/companies/news/38472/glaxosmithkline-sales-hurt-by-european-price-cuts-46004.html Wed, 25 Jul 2012 14:34:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/38472/glaxosmithkline-sales-hurt-by-european-price-cuts-46004.html GlaxoSmithKline to acquire Human Genome Sciences for US$3.6 bln https://www.proactiveinvestors.co.uk/companies/news/38117/glaxosmithkline-to-acquire-human-genome-sciences-for-us36-bln-45575.html Mon, 16 Jul 2012 14:00:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/38117/glaxosmithkline-to-acquire-human-genome-sciences-for-us36-bln-45575.html GlaxoSmithKline set to win Human Genome with enhanced offer say reports https://www.proactiveinvestors.co.uk/companies/news/38100/glaxosmithkline-set-to-win-human-genome-with-enhanced-offer-say-reports-45553.html Mon, 16 Jul 2012 08:34:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/38100/glaxosmithkline-set-to-win-human-genome-with-enhanced-offer-say-reports-45553.html GlaxoSmithKline shares resilient to US$3 bln fine https://www.proactiveinvestors.co.uk/companies/news/37629/glaxosmithkline-shares-resilient-to-us3-bln-fine-44988.html Drugs giant GlaxoSmithKline shares today shrugged off its huge fine for the largest healthcare fraud case in US history.

]]>
Tue, 03 Jul 2012 10:44:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/37629/glaxosmithkline-shares-resilient-to-us3-bln-fine-44988.html
GlaxoSmithKline's smokers' cough drug set for go ahead after positive final trial https://www.proactiveinvestors.co.uk/companies/news/37571/glaxosmithklines-smokers-cough-drug-set-for-go-ahead-after-positive-final-trial-44926.html Mon, 02 Jul 2012 08:28:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/37571/glaxosmithklines-smokers-cough-drug-set-for-go-ahead-after-positive-final-trial-44926.html Human Genome sets July 16 deadline for bids https://www.proactiveinvestors.co.uk/companies/news/36982/human-genome-sets-july-16-deadline-for-bids-44220.html Fri, 15 Jun 2012 14:44:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/36982/human-genome-sets-july-16-deadline-for-bids-44220.html GlaxoSmithKline acquires hand eczema drug Toctino for £146m https://www.proactiveinvestors.co.uk/companies/news/36822/glaxosmithkline-acquires-hand-eczema-drug-toctino-for-146m-44019.html Tue, 12 Jun 2012 10:11:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/36822/glaxosmithkline-acquires-hand-eczema-drug-toctino-for-146m-44019.html GSK amends offer conditions in response to Human Genome Sciences poison pill https://www.proactiveinvestors.co.uk/companies/news/36161/gsk-amends-offer-conditions-in-response-to-human-genome-sciences-poison-pill-43216.html Wed, 23 May 2012 14:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/36161/gsk-amends-offer-conditions-in-response-to-human-genome-sciences-poison-pill-43216.html Human Genome Sciences devises poison pill to ward off GSK bid https://www.proactiveinvestors.co.uk/companies/news/35941/human-genome-sciences-devises-poison-pill-to-ward-off-gsk-bid-42965.html Thu, 17 May 2012 13:19:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/35941/human-genome-sciences-devises-poison-pill-to-ward-off-gsk-bid-42965.html GlaxoSmithKline: Will realism prevail as drugs giant goes hostile with US$2.6bn HGS bid? https://www.proactiveinvestors.co.uk/companies/news/35613/glaxosmithkline-will-realism-prevail-as-drugs-giant-goes-hostile-with-us26bn-hgs-bid--42540.html Shares in GlaxoSmithKline fell in morning trade after it went hostile with its bid to acquire the American biotech Human Genome Sciences.

 

]]>
Wed, 09 May 2012 10:22:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/35613/glaxosmithkline-will-realism-prevail-as-drugs-giant-goes-hostile-with-us26bn-hgs-bid--42540.html
GlaxoSmithKline launches US$2.6 billion hostile bid for US partner - update https://www.proactiveinvestors.co.uk/companies/news/34947/glaxosmithkline-launches-us26-billion-hostile-bid-for-us-partner-update-41701.html Thu, 19 Apr 2012 13:29:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/34947/glaxosmithkline-launches-us26-billion-hostile-bid-for-us-partner-update-41701.html GlaxoSmithKline launches US$2.6 billion hostile bid for US partner https://www.proactiveinvestors.co.uk/companies/news/34945/glaxosmithkline-launches-us26-billion-hostile-bid-for-us-partner-41698.html Thu, 19 Apr 2012 12:23:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/34945/glaxosmithkline-launches-us26-billion-hostile-bid-for-us-partner-41698.html GSK says diabetes treatment progressing in trials https://www.proactiveinvestors.co.uk/companies/news/34465/gsk-says-diabetes-treatment-progressing-in-trials-41079.html Tue, 03 Apr 2012 08:33:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/34465/gsk-says-diabetes-treatment-progressing-in-trials-41079.html GlaxoSmithKline to invest £500m in UK manufacturing capacity https://www.proactiveinvestors.co.uk/companies/news/34065/glaxosmithkline-to-invest-500m-in-uk-manufacturing-capacity-40607.html Thu, 22 Mar 2012 08:52:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/34065/glaxosmithkline-to-invest-500m-in-uk-manufacturing-capacity-40607.html Pharma sector set to outperform this year https://www.proactiveinvestors.co.uk/companies/news/32994/pharma-sector-set-to-outperform-this-year-39288.html The pharmaceuticals sector will continue to outperform this year after a stellar 2011, according to research from Berenberg Bank

]]>
Wed, 22 Feb 2012 11:51:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/32994/pharma-sector-set-to-outperform-this-year-39288.html
Market Overdosed On GSK https://www.proactiveinvestors.co.uk/companies/news/256347/market-overdosed-on-gsk-7707.html In the current environment, the outlook for big pharmaceutical companies is tough. As patents expire, new blockbuster drugs are harder to come by and simultaneously generic drug manufacturers are stealing market share.

]]>
Sat, 10 Dec 2011 10:20:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/256347/market-overdosed-on-gsk-7707.html
Citi reveals the 'killer apps' that will unlock value in pharma sector https://www.proactiveinvestors.co.uk/companies/news/30403/citi-reveals-the-killer-apps-that-will-unlock-value-in-pharma-sector-36334.html Threatened by patent expiries and dwindling healthcare budgets, the pharmaceuticals industry has long been portrayed as being in terminal decline. However reports of its demise would appear to have been greatly exaggerated if the latest research from Citigroup is anything to go by.

]]>
Wed, 30 Nov 2011 13:09:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/30403/citi-reveals-the-killer-apps-that-will-unlock-value-in-pharma-sector-36334.html
GlaxoSmithKline poised to deliver a number of blockbusters, says Matrix Capital https://www.proactiveinvestors.co.uk/companies/news/25687/glaxosmithkline-poised-to-deliver-a-number-of-blockbusters-says-matrix-capital--30657.html Thu, 14 Jul 2011 14:03:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/25687/glaxosmithkline-poised-to-deliver-a-number-of-blockbusters-says-matrix-capital--30657.html Glaxo has taken a few hits during 2010 https://www.proactiveinvestors.co.uk/companies/news/253980/glaxo-has-taken-a-few-hits-during-2010-5331.html Fri, 13 May 2011 15:29:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/253980/glaxo-has-taken-a-few-hits-during-2010-5331.html GlaxoSmithKline faces £2.2bn legal charge after Avandia investigation https://www.proactiveinvestors.co.uk/companies/news/20708/glaxosmithkline-faces-22bn-legal-charge-after-avandia-investigation-24689.html Tue, 18 Jan 2011 07:41:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/20708/glaxosmithkline-faces-22bn-legal-charge-after-avandia-investigation-24689.html Fundamentals in place to boost Glaxo https://www.proactiveinvestors.co.uk/companies/news/252932/fundamentals-in-place-to-boost-glaxo-4284.html Buying Glaxo provides you with a quality blue chip with strong cash flow, robust progressive dividend policy and solid growth forecasts.

]]>
Sat, 15 Jan 2011 05:50:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/252932/fundamentals-in-place-to-boost-glaxo-4284.html
GlaxoSmithKline and Amicus to co-develop Amigal drug for Fabry disease https://www.proactiveinvestors.co.uk/companies/news/18892/glaxosmithkline-and-amicus-to-co-develop-amigal-drug-for-fabry-disease-22588.html Mon, 01 Nov 2010 07:07:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/18892/glaxosmithkline-and-amicus-to-co-develop-amigal-drug-for-fabry-disease-22588.html GlaxoSmithKline to cut cost of cervical cancer vaccine in Canada by 30% https://www.proactiveinvestors.co.uk/companies/news/18747/glaxosmithkline-to-cut-cost-of-cervical-cancer-vaccine-in-canada-by-30-22416.html Tue, 26 Oct 2010 06:18:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/18747/glaxosmithkline-to-cut-cost-of-cervical-cancer-vaccine-in-canada-by-30-22416.html With restructuring charges and legal provisions hitting the second quarter, GlaxoSmithKline recently announced a slight loss https://www.proactiveinvestors.co.uk/companies/news/252062/with-restructuring-charges-and-legal-provisions-hitting-the-second-quarter-glaxosmithkline-recently-announced-a-slight-loss-3410.html Tue, 14 Sep 2010 13:34:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/252062/with-restructuring-charges-and-legal-provisions-hitting-the-second-quarter-glaxosmithkline-recently-announced-a-slight-loss-3410.html GlaxoSmithKline extends presence in Asia with strategic alliance in South Korea https://www.proactiveinvestors.co.uk/companies/news/13499/glaxosmithkline-extends-presence-in-asia-with-strategic-alliance-in-south-korea-16463.html Tue, 11 May 2010 09:21:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/13499/glaxosmithkline-extends-presence-in-asia-with-strategic-alliance-in-south-korea-16463.html GlaxoSmithKline taps into Isis Pharmaceuticals antisense drug platform https://www.proactiveinvestors.co.uk/companies/news/12315/glaxosmithkline-taps-into-isis-pharmaceuticals-antisense-drug-platform-15104.html Wed, 31 Mar 2010 11:01:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/12315/glaxosmithkline-taps-into-isis-pharmaceuticals-antisense-drug-platform-15104.html Simcere Phrama gets China regulator approval to market generic version of GSK’s Relenza https://www.proactiveinvestors.co.uk/companies/news/10651/simcere-phrama-gets-china-regulator-approval-to-market-generic-version-of-gsks-relenza--13224.html Thu, 11 Feb 2010 14:14:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/10651/simcere-phrama-gets-china-regulator-approval-to-market-generic-version-of-gsks-relenza--13224.html Seattle Genetics in drug-antibodies collaboration with GlaxoSmithKline https://www.proactiveinvestors.co.uk/companies/news/9224/seattle-genetics-in-drug-antibodies-collaboration-with-glaxosmithkline-11592.html Mon, 21 Dec 2009 12:05:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/9224/seattle-genetics-in-drug-antibodies-collaboration-with-glaxosmithkline-11592.html GlaxoSmithKline Builds On Aspen Pharmacare Partnership https://www.proactiveinvestors.co.uk/companies/news/8583/glaxosmithkline-builds-on-aspen-pharmacare-partnership-10805.html Tue, 01 Dec 2009 09:21:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/8583/glaxosmithkline-builds-on-aspen-pharmacare-partnership-10805.html GlaxoSmithKline Reaches Efficacy Endpoint In Lupus Drug’s Phase 3 Trial https://www.proactiveinvestors.co.uk/companies/news/7603/glaxosmithkline-reaches-efficacy-endpoint-in-lupus-drugs-phase-3-trial--9699.html Mon, 02 Nov 2009 07:23:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/7603/glaxosmithkline-reaches-efficacy-endpoint-in-lupus-drugs-phase-3-trial--9699.html Vernalis lands US$200 million deal from GlaxoSmithKline https://www.proactiveinvestors.co.uk/companies/news/5270/vernalis-lands-us200-million-deal-from-glaxosmithkline-7095.html Thu, 06 Aug 2009 07:37:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/5270/vernalis-lands-us200-million-deal-from-glaxosmithkline-7095.html Biota to benefit as GlaxoSmithKline aims to triple capacity for swine flu drug, Relenza https://www.proactiveinvestors.co.uk/companies/news/5000/biota-to-benefit-as-glaxosmithkline-aims-to-triple-capacity-for-swine-flu-drug-relenza-6780.html Thu, 23 Jul 2009 08:55:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/5000/biota-to-benefit-as-glaxosmithkline-aims-to-triple-capacity-for-swine-flu-drug-relenza-6780.html GSK unmoved after releasing Q2 and H1 results https://www.proactiveinvestors.co.uk/companies/news/4987/gsk-unmoved-after-releasing-q2-and-h1-results-6767.html Wed, 22 Jul 2009 12:54:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/4987/gsk-unmoved-after-releasing-q2-and-h1-results-6767.html GlaxoSmithKline and Shenzhen Neptunus create alliance to manufacture flu vaccines in China https://www.proactiveinvestors.co.uk/companies/news/4376/glaxosmithkline-and-shenzhen-neptunus-create-alliance-to-manufacture-flu-vaccines-in-china-6033.html Tue, 09 Jun 2009 06:24:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/4376/glaxosmithkline-and-shenzhen-neptunus-create-alliance-to-manufacture-flu-vaccines-in-china-6033.html GlaxoSmithKline – A defensive remedy https://www.proactiveinvestors.co.uk/companies/news/4335/glaxosmithkline-a-defensive-remedy-5981.html Fri, 05 Jun 2009 07:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/4335/glaxosmithkline-a-defensive-remedy-5981.html GSK gets several government orders for new swine flu vaccine https://www.proactiveinvestors.co.uk/companies/news/4077/gsk-gets-several-government-orders-for-new-swine-flu-vaccine-5674.html Fri, 15 May 2009 11:59:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/4077/gsk-gets-several-government-orders-for-new-swine-flu-vaccine-5674.html GlaxoSmithKline extends strategic collaboration with SAfrica’s Aspen, takes 16 pct stake https://www.proactiveinvestors.co.uk/companies/news/4005/glaxosmithkline-extends-strategic-collaboration-with-safricas-aspen-takes-16-pct-stake--5588.html Tue, 12 May 2009 07:30:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/4005/glaxosmithkline-extends-strategic-collaboration-with-safricas-aspen-takes-16-pct-stake--5588.html GlaxoSmithKline to sell US rights for Wellbutrin XL to Biovail for US$510 mln https://www.proactiveinvestors.co.uk/companies/news/3926/glaxosmithkline-to-sell-us-rights-for-wellbutrin-xl-to-biovail-for-us510-mln-5499.html Wed, 06 May 2009 07:27:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/3926/glaxosmithkline-to-sell-us-rights-for-wellbutrin-xl-to-biovail-for-us510-mln-5499.html GlaxoSmithKline buys dermatology group Stiefel Labs for up to US$3.6 billion https://www.proactiveinvestors.co.uk/companies/news/3727/glaxosmithkline-buys-dermatology-group-stiefel-labs-for-up-to-us36-billion--5261.html Mon, 20 Apr 2009 08:28:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/3727/glaxosmithkline-buys-dermatology-group-stiefel-labs-for-up-to-us36-billion--5261.html GlaxoSmithKline and Pfizer to create specialist HIV company https://www.proactiveinvestors.co.uk/companies/news/3699/glaxosmithkline-and-pfizer-to-create-specialist-hiv-company-5227.html Thu, 16 Apr 2009 10:35:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/3699/glaxosmithkline-and-pfizer-to-create-specialist-hiv-company-5227.html GlaxoSmithKline to buy UCB emerging markets product portfolio for €515 million cash https://www.proactiveinvestors.co.uk/companies/news/2830/glaxosmithkline-to-buy-ucb-emerging-markets-product-portfolio-for-515-million-cash-4127.html Fri, 23 Jan 2009 08:03:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/2830/glaxosmithkline-to-buy-ucb-emerging-markets-product-portfolio-for-515-million-cash-4127.html GlaxoSmithKline acquires Bristol-Myers Squibb's Pakistan business https://www.proactiveinvestors.co.uk/companies/news/2606/glaxosmithkline-acquires-bristol-myers-squibbs-pakistan-business-3847.html Mon, 22 Dec 2008 11:23:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/2606/glaxosmithkline-acquires-bristol-myers-squibbs-pakistan-business-3847.html GlaxoSmithKline to enter flu vaccine JV in China https://www.proactiveinvestors.co.uk/companies/news/2357/glaxosmithkline-to-enter-flu-vaccine-jv-in-china--3528.html Fri, 21 Nov 2008 11:07:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/2357/glaxosmithkline-to-enter-flu-vaccine-jv-in-china--3528.html